top of page
News
Centene to pay $66.5 million in Indiana Medicaid drug pricing settlement
Health care services company Centene Corp. will pay Indiana nearly $66.5 million to resolve allegations that it overcharged the state’s...
Feb 1, 2023
Corporate bad actors make billions from abusing program designed to help low-income patients | Guest
Large hospital systems and pharmacy benefit managers have been taking advantage of a federal program for far too long, netting billions...
Jan 21, 2023
Why Now Is the Time for Health Plans to Take Control of Pharmacy Benefits
Health plans today must consider what they want out of their pharmacy benefits and how to achieve something better for their members. And...
Jan 20, 2023
It is Time for Policymakers to Protect Patients from Predatory Practices of Insurers and PBMs
Although per capita patient out-of-pocket (OOP) spending on prescription medications has dropped, averages are deceiving. In the U.S., a...
Jan 15, 2023
Lawmakers are readying fresh attacks on pharmacy middlemen
As key lawmakers gear up for the new Congress, there’s at least one industry that will be caught in the crosshairs: pharmacy benefit...
Jan 14, 2023
With the FTC’s more expansive approach to antitrust, PBMs are in the crosshairs
WASHINGTON — The Democrats leading the Federal Trade Commission are hoping to expand the agency’s authority to crack down on unfair...
Jan 13, 2023
Congress Can Stop Pharmacy Benefit Managers from Manipulating Patients
Millions of Americans rely on prescription medications to manage their illnesses. According to polling conducted by the Kaiser Family...
Jan 6, 2023
The PBM defense playbook
Congress isn't exactly off to a running start. But when the House gets its act together, one of the top potential areas for bipartisan...
Jan 5, 2023
Drug Pricing Oversight to Get Prime Focus Under New Congress
Overseeing Medicare’s new authority to negotiate prices of the country’s highest-spending drugs is among the top priorities for lawmakers...
Jan 3, 2023
Opinion: Fixing price instability can improve access to affordable prescription drugs
The high cost of prescription drugs is a very real problem in the United States. The average American spends approximately $1,300 per...
Dec 15, 2022
Commentary: Don't let insurers just pocket prescription co-pay aid
Family physicians care for patients young and old throughout their lives. It is often our duty to tell a patient that he or she has a...
Dec 15, 2022
New report on Oregon pharmacy reimbursement abuses reaffirms need for industry reforms
A recent report out of Oregon found “significant disparities in reimbursement” between retail pharmacies in the study and all other...
Dec 1, 2022
Pharmacy Benefit Manager Reform Remains Legislative Priority
The 2022 midterms have concluded, but the Republican underperformance is not expected to dampen Congressional enthusiasm for Pharmacy...
Nov 22, 2022
Opinion: Republicans can stand up for patients by lowering out-of-pocket costs
As COVID-19 has dominated health care resources over the past several years, people living with chronic illnesses have faced even greater...
Nov 17, 2022
National Community Pharmacists Association (NCPA) comments to the Federal Trade Commission
The National Community Pharmacists Association (NCPA) welcomes the opportunity to provide comments to the Federal Trade Commission on the...
Nov 4, 2022
New Study: Inequity in PBMs’ Drug Pricing Practices in Oregon Raises Serious Questions
The Oregon State Pharmacy Association (OSPA), in collaboration with 3 Axis Advisors, released a report today that illustrates the...
Oct 27, 2022
Prescription drug pricing reform must rein in pharmacy benefit managers
This month, President Biden signed an executive order directing federal health departments to create plans within 90 days to lower...
Oct 18, 2022
Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, & Providers: A 2022 Update
I conservatively estimate that I’ve created about 1,374,613 slides during my career. But there are two slides that people seem to...
Oct 13, 2022
Opinion: Reforms will lower prescription drug costs for patients and taxpayers
In a win for Texas taxpayers, the state government recently secured $165 million in a lawsuit alleging that the pharmacy benefit manager...
Oct 12, 2022
Medicare Advantage gets exploited by insurers
Insurers have been employing lucrative strategies to milk more money from the federal Medicare Advantage program than they may legally be...
Oct 11, 2022
PBM Accountability Project Managing Director Mark Blum Joins Pharmacy Podcast Network
Today we are hoping to make sense of the Inflation Reduction Act which is designed to protect Medicare recipients from catastrophic drug...
Oct 4, 2022
Time to Rein in the Drug-Industry Middlemen Exploiting Patients
Last month, lawmakers missed a big chance to lower the cost of prescription medicine. Despite including a host of new drug-pricing...
Sep 27, 2022
The Middleman Mentality Is Killing American Medicine
Between producers and consumers, you’ll find a cadre of professionals who broker deals, facilitate transactions, and move goods and...
Sep 26, 2022
Pharmacy Middlemen Deserve Reformers' Attention
Drug pricing reform has received renewed attention in recent months, but one entity always seems to escape unscathed in reform efforts:...
Aug 30, 2022
bottom of page
